Monogenetic disorders testing is refer to as the procedure of testing a disorder related to monogenetic. While the monogenetic disorder is inherited because of the single defective gene on the autosomes. Monogenic disorders are caused by a single mutated gene which is present either on single or both chromosomes. Males and females are equally affected by such kind of disorder due to the conditions on autosomes. Some of the tests available for the mainstream of the common monogenic disorders are Cystic fibrosis, SCID, Tay-sachs disease, polycystic kidney disorder, sickle cell anemia, Gaucher's disease, Huntington's disease, thalassaemia, neurofibromatosis, and familial hypercholesterolemia.
- Rising awareness of genetic disorders among the population
- Availability of advanced technological platforms and improved genomic tools
- Increasing prevalence of monogenic disorders throughout the globe
- Lack of skilled professionals, and lack of knowledge
Increasing investment by the hospital facilities and government for better healthcare
Players Covered in the Study are:
Celera Group (United States), Abbott (United States), Thermo Fisher Scientific (United States), ELITech Group (France), DescriptionQuest Diagnostics (United States), AutoGenomics (United States), PerkinElmer (United States), Roche (Switzerland) and Bio-Rad (United States)